StockMacro
Company, fund or insider

Help

Menu

Envista

$22.91 -2.5% in 6 monthsMarket cap $3.7B

NVST on XNYS, Health Care, Envista Holdings Corporation, job postings

Measures activity, not value. Not investment advice.

Net income jumped 4041% to $633.6M over 12 months while quarterly revenue rose 3.2%.

  • GoodRevenue up 9.8% to $2.9B over 12 months
  • WatchCapital spending up 49% to $16.1M this quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 2 Oct 2026

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Industry
Dental equipment & supplies (Health Care)
Employees
12,000
Website
envistaco.com
Listed
NYSE, US
Last results
4 Nov 2026
Next results
expected around 4 Feb 2027 (an estimate: a year ago it reported on 5 Feb 2026)
Revenue and net income per quarter. Quarter to 2 Oct 2026: revenue $691.5M, net income $508.3M.
Quarter to 31 Dec 2021: revenue $651.8M, net income $85.8MQuarter to 31 Dec 2021: revenue $651.8M, net income $85.8MQuarter to 1 Apr 2022: revenue $631.4M, net income $74.9MQuarter to 1 Apr 2022: revenue $631.4M, net income $74.9MQuarter to 1 Jul 2022: revenue $645.8M, net income $47.1MQuarter to 1 Jul 2022: revenue $645.8M, net income $47.1MQuarter to 30 Sep 2022: revenue $631.1M, net income $47.6MQuarter to 30 Sep 2022: revenue $631.1M, net income $47.6MQuarter to 31 Dec 2022: revenue –, net income $73.5MQuarter to 31 Mar 2023: revenue $627.2M, net income $43.8MQuarter to 31 Mar 2023: revenue $627.2M, net income $43.8MQuarter to 30 Jun 2023: revenue $662.4M, net income $51.9MQuarter to 30 Jun 2023: revenue $662.4M, net income $51.9MQuarter to 29 Sep 2023: revenue $631.3M, net income $21.5MQuarter to 29 Sep 2023: revenue $631.3M, net income $21.5MQuarter to 31 Dec 2023: revenue $645.6M, net income -$217.4MQuarter to 31 Dec 2023: revenue $645.6M, net income -$217.4MQuarter to 29 Mar 2024: revenue $623.6M, net income $23.6MQuarter to 29 Mar 2024: revenue $623.6M, net income $23.6MQuarter to 28 Jun 2024: revenue $633.1M, net income -$1.2BQuarter to 28 Jun 2024: revenue $633.1M, net income -$1.2BQuarter to 27 Sep 2024: revenue $601.0M, net income $8.2MQuarter to 27 Sep 2024: revenue $601.0M, net income $8.2MQuarter to 31 Dec 2024: revenue $652.9M, net income $1.2MQuarter to 31 Dec 2024: revenue $652.9M, net income $1.2MQuarter to 28 Mar 2025: revenue $616.9M, net income $18.0MQuarter to 28 Mar 2025: revenue $616.9M, net income $18.0MQuarter to 27 Jun 2025: revenue $682.1M, net income $26.4MQuarter to 27 Jun 2025: revenue $682.1M, net income $26.4MQuarter to 26 Sep 2025: revenue $669.9M, net income -$30.3MQuarter to 26 Sep 2025: revenue $669.9M, net income -$30.3MQuarter to 31 Dec 2025: revenue $750.6M, net income $32.9MQuarter to 31 Dec 2025: revenue $750.6M, net income $32.9MQuarter to 3 Apr 2026: revenue $705.5M, net income $38.7MQuarter to 3 Apr 2026: revenue $705.5M, net income $38.7MQuarter to 3 Jul 2026: revenue $730.5M, net income $53.7MQuarter to 3 Jul 2026: revenue $730.5M, net income $53.7MQuarter to 2 Oct 2026: revenue $691.5M, net income $508.3MQuarter to 2 Oct 2026: revenue $691.5M, net income $508.3M
31 Dec 2021RevenueNet incomeNet losstallest bar $1.2B2 Oct 2026
See the numbers
Quarter toRevenueNet income
2 Oct 2026$691.5M$508.3M
3 Jul 2026$730.5M$53.7M
3 Apr 2026$705.5M$38.7M
31 Dec 2025$750.6M$32.9M
26 Sep 2025$669.9M-$30.3M
27 Jun 2025$682.1M$26.4M
28 Mar 2025$616.9M$18.0M
31 Dec 2024$652.9M$1.2M
27 Sep 2024$601.0M$8.2M
28 Jun 2024$633.1M-$1.2B
29 Mar 2024$623.6M$23.6M
31 Dec 2023$645.6M-$217.4M
29 Sep 2023$631.3M$21.5M
30 Jun 2023$662.4M$51.9M
31 Mar 2023$627.2M$43.8M
31 Dec 2022–$73.5M
30 Sep 2022$631.1M$47.6M
1 Jul 2022$645.8M$47.1M
1 Apr 2022$631.4M$74.9M
31 Dec 2021$651.8M$85.8M
Fundamentals, 12 months to 2 Oct 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $2.9B $2.6B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +9.8% +9.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $633.6M $15.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $3.87 $0.09
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 55.9% 55.3% 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 25.4% 7.2% -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 22.0% 0.6% -7.6%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 20.5% -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $242.0M $262.5M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $1.2B $1.1B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.4B $1.4B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $270.2M $311.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.46 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $19.26
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 5.8 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.3 3.2
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.4 3.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.2 2.2

Latest = 12 months to 2 Oct 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
EnvistaNVST (this company) $3.7B5.81.3+9.8%22.0%
Dentsply SironaXRAY $1.7Bloss0.46-1.4%-3.4%
CareDxCDNA $3.7B28.67.4+39%25.9%
Tango TherapeuticsTNGX $3.7Bloss–––
OrganonOGN $3.6B17.10.60-3.2%3.5%
Xenon PharmaceuticalsXENE $3.6Bloss–––

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.2%

$691.5M vs $669.9M (quarter ended 2 Oct 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+49%

$16.1M vs $10.8M (quarter ended 2 Oct 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$220K

bought $0, sold $220K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+7.2%

403 13F filers vs 376

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

199.8M shares held by 13F filers (30 Sep 2026) of 160.3M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

6.1%

9.7M shares sold short (30 Oct 2026) of 160.3M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.0

9.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-0.5%

9.8M shares sold short in the report before, 9.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

63%

63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

278

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$80K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

0

0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $22.91 on 20 Nov 2026, +20% over 12 months (12-month range $19.11 to $30.26)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $510K in the last 12 months (the 12 months before: -$324K).
Revenue per quarter. Revenue $691.5M in the latest quarter, +3.2% on a year earlier.
Capital spending per quarter. Capital spending $16.1M in the latest quarter, +49% on a year earlier.
Institutional holders (13F filers). 403 13F filers reported holding it in the latest 13F quarter, +38% on a year earlier.
Lobbying spend. Lobbying spend: $80K published in the last 12 months, 0% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
19 Aug 20268-K and other filingsDirector or officer change
3 Jun 20268-K and other filingsDirector or officer change
3 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 81 vs usual 40 (2026-03-31); 2.0x the same period a year earlier
17 Sep 20258-K and other filingsDirector or officer change
16 Jul 20258-K and other filingsDirector or officer change
16 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Oct 2024Sharp changeShort interest spike: short interest spike, 18.1M vs usual 9.6M (2024-09-30); 3.2x the same period a year earlier
16 Jul 2024Sharp changeShort interest spike: short interest spike, 16.4M vs usual 8.8M (2024-06-28); 1.7x the same period a year earlier
15 Jul 20248-K and other filingsDirector or officer change
30 May 20248-K and other filingsDirector or officer change
15 Apr 20248-K and other filingsDirector or officer change
26 Feb 20248-K and other filingsDirector or officer change
14 Dec 20238-K and other filingsDirector or officer change
14 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Nov 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 367K)
26 Jul 20238-K and other filingsDirector or officer change
30 Jun 20238-K and other filingsDirector or officer change
14 Apr 20238-K and other filingsDirector or officer change
14 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Mar 20228-K and other filingsDirector or officer change
30 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Dec 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Dec 2021: -$4.3M published
Month from 1 Feb 2022: -$288K published
Month from 1 Mar 2022: -$15.7M published
Month from 1 Apr 2022: -$789K published
Month from 1 Nov 2022: -$24K published
Month from 1 Mar 2023: -$380K published
Month from 1 Nov 2023: $417K published
Month from 1 Aug 2024: $907K published
Month from 1 Aug 2025: -$324K published
Month from 1 Feb 2026: -$290K published
Month from 1 Aug 2026: -$220K published
Revenue per quarter
Quarter ended 31 Dec 2021: $651.8M, -11% on a year earlier; public on 25 Feb 2022
Quarter ended 1 Apr 2022: $631.4M, -11% on a year earlier; public on 5 May 2022
Quarter ended 1 Jul 2022: $645.8M, -13% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $631.1M, +3.9% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Mar 2023: $627.2M, -0.7% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $662.4M, +2.6% on a year earlier; public on 3 Aug 2023
Quarter ended 29 Sep 2023: $631.3M, 0% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $645.6M; public on 16 Feb 2024
Quarter ended 29 Mar 2024: $623.6M, -0.6% on a year earlier; public on 2 May 2024
Quarter ended 28 Jun 2024: $633.1M, -4.4% on a year earlier; public on 8 Aug 2024
Quarter ended 27 Sep 2024: $601.0M, -4.8% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $652.9M, +1.1% on a year earlier; public on 14 Feb 2025
Quarter ended 28 Mar 2025: $616.9M, -1.1% on a year earlier; public on 2 May 2025
Quarter ended 27 Jun 2025: $682.1M, +7.7% on a year earlier; public on 1 Aug 2025
Quarter ended 26 Sep 2025: $669.9M, +11% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $750.6M, +15% on a year earlier; public on 13 Feb 2026
Quarter ended 3 Apr 2026: $705.5M, +14% on a year earlier; public on 7 May 2026
Quarter ended 3 Jul 2026: $730.5M, +7.1% on a year earlier; public on 6 Aug 2026
Quarter ended 2 Oct 2026: $691.5M, +3.2% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $8.7M, -34% on a year earlier; public on 25 Feb 2022
Quarter ended 1 Apr 2022: $19.8M, +139% on a year earlier; public on 5 May 2022
Quarter ended 1 Jul 2022: $12.1M, -40% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $26.9M, +54% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $16.9M, +94% on a year earlier; public on 17 Feb 2023
Quarter ended 31 Mar 2023: $17.5M, -12% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $14.1M, +17% on a year earlier; public on 3 Aug 2023
Quarter ended 29 Sep 2023: $18.4M, -32% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $8.2M, -51% on a year earlier; public on 16 Feb 2024
Quarter ended 29 Mar 2024: $11.0M, -37% on a year earlier; public on 2 May 2024
Quarter ended 28 Jun 2024: $6.8M, -52% on a year earlier; public on 8 Aug 2024
Quarter ended 27 Sep 2024: $7.4M, -60% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $8.6M, +4.9% on a year earlier; public on 14 Feb 2025
Quarter ended 28 Mar 2025: $5.9M, -46% on a year earlier; public on 2 May 2025
Quarter ended 27 Jun 2025: $12.3M, +81% on a year earlier; public on 1 Aug 2025
Quarter ended 26 Sep 2025: $10.8M, +46% on a year earlier; public on 31 Oct 2025
Quarter ended 31 Dec 2025: $16.3M, +90% on a year earlier; public on 13 Feb 2026
Quarter ended 3 Apr 2026: $12.5M, +112% on a year earlier; public on 7 May 2026
Quarter ended 3 Jul 2026: $14.9M, +21% on a year earlier; public on 6 Aug 2026
Quarter ended 2 Oct 2026: $16.1M, +49% on a year earlier; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 295; public on 14 Feb 2022
31 Mar 2022 report: 337; public on 16 May 2022
30 Jun 2022 report: 316; public on 15 Aug 2022
30 Sep 2022 report: 287; public on 14 Nov 2022
31 Dec 2022 report: 299; public on 14 Feb 2023
31 Mar 2023 report: 290; public on 15 May 2023
30 Jun 2023 report: 290; public on 14 Aug 2023
30 Sep 2023 report: 287; public on 14 Nov 2023
31 Dec 2023 report: 299; public on 14 Feb 2024
31 Mar 2024 report: 290; public on 15 May 2024
30 Jun 2024 report: 278; public on 14 Aug 2024
30 Sep 2024 report: 275; public on 14 Nov 2024
31 Dec 2024 report: 279; public on 14 Feb 2025
31 Mar 2025 report: 278; public on 15 May 2025
30 Jun 2025 report: 271; public on 14 Aug 2025
30 Sep 2025 report: 292; public on 14 Nov 2025
31 Dec 2025 report: 320; public on 17 Feb 2026
31 Mar 2026 report: 378; public on 15 May 2026
30 Jun 2026 report: 376; public on 14 Aug 2026
30 Sep 2026 report: 403; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $40K published
Quarter from 1 Apr 2022: $40K published
Quarter from 1 Jul 2022: $40K published
Quarter from 1 Oct 2022: $40K published
Quarter from 1 Jan 2023: $20K published
Quarter from 1 Apr 2023: $20K published
Quarter from 1 Jul 2023: $20K published
Quarter from 1 Oct 2023: $20K published
Quarter from 1 Jan 2024: $20K published
Quarter from 1 Apr 2024: $20K published
Quarter from 1 Jul 2024: $20K published
Quarter from 1 Oct 2024: $20K published
Quarter from 1 Jan 2025: $20K published
Quarter from 1 Apr 2025: $20K published
Quarter from 1 Jul 2025: $20K published
Quarter from 1 Oct 2025: $20K published
Quarter from 1 Jan 2026: $20K published
Quarter from 1 Apr 2026: $20K published
Quarter from 1 Jul 2026: $20K published
Quarter from 1 Oct 2026: $20K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is 13F holders (funds reporting the stock) at 403 (30 Sep 2026), 1.4× its normal reading; higher than 100% of its own history.
  • Insider net buying (open market): Insiders sold a net $510K in the last 12 months (the 12 months before: -$324K).
  • Revenue per quarter: Revenue $691.5M in the latest quarter, +3.2% on a year earlier.
  • Capital spending per quarter: Capital spending $16.1M in the latest quarter, +49% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 60 insider trades

No trades in the last 90 days; the latest was filed 24 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
24 Aug 2026Mischa ReisSVP, Strategy & Bus. Dev.Sellplanned in advance (10b5-1)8,000$27.50$220KForm 4
11 Feb 2026Mischa ReisSVP, Strategy & Bus. Dev.Sellplanned in advance (10b5-1); after exercising options9,675$30.00$290KForm 4
27 Aug 2025Mischa ReisSVP, Strategy & Bus. Dev.Sellplanned in advance (10b5-1)15,000$21.60$324KForm 4
14 Aug 2024Paul A KeelChief Executive OfficerBuy30,000$16.87$506KForm 4
13 Aug 2024Eric D. HammesChief Financial OfficerBuy24,532$16.33$401KForm 4
20 Nov 2023Eric ConleySVP, OrthodonticsBuy2,185$22.89$50KForm 4
9 Nov 2023Mark E NanceGeneral CounselBuy5,000$21.75$109KForm 4
7 Nov 2023Stephen KellerPrincipal Financial OfficerBuy2,000$21.53$43KForm 4

403 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 64 opened a position, 38 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.18.9M11.8%$443.3M+450K+2.4%
Dimensional Fund Advisors LP9.7M6.08%$228.7M+176K+1.8%
Ariel Investments, LLC9.5M5.90%$222.0M-358K-3.6%
AQR Capital Management LLC8.5M5.30%$198.5M+4.5M+111%
Ilex Capital Partners (UK) LLP7.6M4.71%$177.2M+3.2M+73%
Vanguard Portfolio Management LLC7.4M4.63%$174.1M-68K-0.9%
Vanguard Capital Management LLC7.1M4.44%$167.2M-214K-2.9%
Arrowstreet Capital, Limited Partnership6.7M4.20%$158.1M+1.9M+39%
Morgan Stanley6.7M4.16%$156.6M+237K+3.7%
American Century Companies Inc5.3M3.31%$124.5M+2.3M+74%

Company events

All 34 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
19 Aug 2026Director or officer change8-K
3 Jun 2026Director or officer change8-K
17 Sep 2025Director or officer change8-K
16 Jul 2025Director or officer change8-K
15 Jul 2024Director or officer change8-K
30 May 2024Director or officer change8-K
15 Apr 2024Director or officer change8-K
26 Feb 2024Director or officer change8-K

278 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 18%, Manufacturing & production 12%, Software engineering 5%, Test, quality & reliability 5%.

PostedJobLocation
21 Nov 2026or earlierNobel Procera SpecialistCHN - SHANGHAI - Kavo Sybron Dental (Shanghai) Co., Ltd - FCH0199
21 Nov 2026or earlierSoftware Development Manager( (Cloud/Web Applications)Software engineeringRUS - Moscow - Stanislavskogo Bldg. 2 - Multiple OpCo
21 Nov 2026or earlierSetter/operatorCZE - Jicin - Multiple OpCo
21 Nov 2026or earlierTeam LeaderCZE - Jicin - Multiple OpCo
21 Nov 2026or earlierSoftware Web Developer- IOSSoftware engineeringFrance, Ile-de-France
21 Nov 2026or earlierClinical Performance LeaderMexico, Baja California Norte, Mexicali
21 Nov 2026or earlierClinical Performance LeaderMexico, Baja California Norte, Mexicali
21 Nov 2026or earlierMAINTENANCE TECHNICIANManufacturing & productionITA - Scafati (SA) - Kerr Italia S.r.l.

Reported lobbying spend: $20K in Q3 2026, $20K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Apr 2021NewSims Strategies, LLCfor Envista Holdings CorporationDental IssuesHealth issuesFiling
Timeline

Timeline

Changes and notable records, by the date each became public

  1. 19 Aug 2026Filings record

    Director or officer change

  2. 3 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 3 Jun 2026Filings record

    Director or officer change

  4. 15 May 2026Institutional holdings change

    saw 81 13F filers open a new position in the quarter ended 31 Mar 2026, 2.0× the same quarter last year.

    Same quarter last year: 41; its normal quarter is 40.

    See the evidence
    This period
    81 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    40
    Typical spread (median absolute deviation)
    7.5
    How far from its usual level
    +3.7
    Same quarter last year
    41
    History used
    2,374 days
    2024-03-31: 352024-06-30: 242024-09-30: 442024-12-31: 252025-03-31: 412025-06-30: 392025-09-30: 562025-12-31: 502026-03-31: 81
    the quarter ended 31 Mar 20268 earlier quartersnormal: 40

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  5. 17 Sep 2025Filings record

    Director or officer change

  6. 16 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 16 Jul 2025Filings record

    Director or officer change

  8. 10 Oct 2024Short interest and volume change

    had 18.1M shares sold short in the 30 Sep 2024 report, 3.2× the same report last year.

    Same report last year: 5.6M; its normal report is 9.6M.

    See the evidence
    This period
    18.1M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    9.6M
    Typical spread (median absolute deviation)
    1.5M
    How far from its usual level
    +3.8
    Same report last year
    5.6M
    History used
    1,827 days
    2023-09-29: 5.6M2023-10-13: 5.8M2023-10-31: 7.6M2023-11-15: 8.7M2023-11-30: 8.6M2023-12-15: 11.5M2023-12-29: 10.6M2024-01-12: 9.0M2024-01-31: 9.9M2024-02-15: 8.2M2024-02-29: 8.6M2024-03-15: 8.8M2024-03-28: 10.8M2024-04-15: 9.4M2024-04-30: 11.8M2024-05-15: 9.0M2024-05-31: 12.2M2024-06-14: 8.9M2024-06-28: 16.4M2024-07-15: 11.2M2024-07-31: 11.2M2024-08-15: 13.0M2024-08-30: 15.7M2024-09-13: 16.3M2024-09-30: 18.1M
    the 30 Sep 2024 report24 earlier reportsnormal: 9.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 15 Aug 2024Insiders record

    Keel Paul A (Chief Executive Officer) bought 30,000 shares of NVST ($506,100) (dated 14 Aug 2024)

  10. 14 Aug 2024Insiders record

    Hammes Eric D. (Chief Financial Officer) bought 24,532 shares of NVST ($400,608) (dated 13 Aug 2024)

  11. 15 Jul 2024Filings record

    Director or officer change

  12. 11 Jul 2024Short interest and volume change

    had 16.4M shares sold short in the 28 Jun 2024 report, 1.7× the same report last year.

    Same report last year: 9.7M; its normal report is 8.8M.

    See the evidence
    This period
    16.4M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    8.8M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +5.0
    Same report last year
    9.7M
    History used
    1,733 days
    2023-06-30: 9.7M2023-07-14: 8.8M2023-07-31: 8.6M2023-08-15: 6.0M2023-08-31: 4.8M2023-09-15: 5.9M2023-09-29: 5.6M2023-10-13: 5.8M2023-10-31: 7.6M2023-11-15: 8.7M2023-11-30: 8.6M2023-12-15: 11.5M2023-12-29: 10.6M2024-01-12: 9.0M2024-01-31: 9.9M2024-02-15: 8.2M2024-02-29: 8.6M2024-03-15: 8.8M2024-03-28: 10.8M2024-04-15: 9.4M2024-04-30: 11.8M2024-05-15: 9.0M2024-05-31: 12.2M2024-06-14: 8.9M2024-06-28: 16.4M
    the 28 Jun 2024 report24 earlier reportsnormal: 8.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 30 May 2024Filings record

    Director or officer change

  14. 15 Apr 2024Filings record

    Director or officer change

  15. 26 Feb 2024Filings record

    Director or officer change

  16. 14 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 14 Dec 2023Filings record

    Director or officer change

  18. 21 Nov 2023Insiders record

    Conley Eric (SVP, Orthodontics) bought 2,185 shares of NVST ($50,015) (dated 20 Nov 2023)

  19. 10 Nov 2023Insiders change

    had 3 insiders buy $367K of its shares on the open market within 30 days (3 filings).

    Who bought: Aghdaei Amir, Keller Stephen, Nance Mark E.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $367K
    Window
    11 Oct 2023 to 10 Nov 2023

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  20. 10 Nov 2023Insiders record

    Nance Mark E (General Counsel) bought 5,000 shares of NVST ($108,750) (dated 9 Nov 2023)

  21. 8 Nov 2023Insiders record

    Keller Stephen (Principal Financial Officer) bought 2,000 shares of NVST ($43,060) (dated 7 Nov 2023)

  22. 8 Nov 2023Insiders record

    Aghdaei Amir (Chief Executive Officer) bought 10,000 shares of NVST ($215,253) (dated 7 Nov 2023)

  23. 26 Jul 2023Filings record

    Director or officer change

  24. 30 Jun 2023Filings record

    Director or officer change

  25. 14 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 14 Apr 2023Filings record

    Director or officer change

  27. 30 Mar 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 30 Mar 2022Filings record

    Director or officer change

  29. 3 Dec 2021Filings record

    Director or officer change

  30. 12 Nov 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 12 Nov 2021Filings record

    Director or officer change

  32. 14 May 2021Lobbying change

    registered for federal lobbying for the first time in our data (Sims Strategies, Llc).

    See the evidence (1 source record)
    Source coverage starts
    6 Apr 2010
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  33. 14 May 2021Lobbying record

    ENVISTA HOLDINGS CORPORATION: new lobbying registration (SIMS STRATEGIES, LLC) (dated 1 Apr 2021)

  34. 5 Nov 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 5 Nov 2020Filings record

    Director or officer change

  36. 4 Aug 2020Financials change

    reported revenue of $362.0M for the quarter ended 3 Jul 2020, 49% below the same quarter last year.

    Same quarter last year: $712.1M; its normal quarter is $695.8M.

    See the evidence
    This period
    $362.0M (the quarter ended 3 Jul 2020)
    Normal quarter (median of 8 earlier)
    $695.8M
    Typical spread (median absolute deviation)
    $36.3M
    How far from its usual level
    -4.8
    Same quarter last year
    $712.1M
    History used
    826 days
    2018-06-29: $733.4M2018-09-28: $679.5M2018-12-31: $759.0M2019-03-29: $659.7M2019-06-28: $712.1M2019-09-27: $659.3M2019-12-31: $720.5M2020-04-03: $547.2M2020-07-03: $362.0M
    the quarter ended 3 Jul 20208 earlier quartersnormal: $695.8M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  37. 31 Jul 2020Filings record

    Director or officer change

  38. 11 May 2020Filings record

    Director or officer change

  39. 8 Apr 2020Filings record

    Director or officer change

  40. 2 Apr 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 54 entries; narrow the window or the kind of data to see older ones.

Not listed: 121 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001757073
Ticker
NVST
Domain
envistaco.com
Employer name
envista
Hq location
CA|BREA|92821 (1 unverified)
Lobbying client
envista holdings
Name
Envista Holdings Corporation
Wikidata
Q106295182
  • DOL H-1B labor condition applications and PERM certifications3 data points20 Jul 2026 to 10 Aug 2026
  • Federal lobbying disclosures (LDA)1 record, 66 data points1 Apr 2021 to 30 Sep 2026
  • SEC Form 13F institutional holdings261 data points30 Sep 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)98 records22 Jul 2019 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)620 data points31 Dec 2016 to 30 Oct 2026
  • SEC Form 4 insider transactions60 records, 160 data points24 Sep 2019 to 24 Aug 2026
  • FINRA short interest (twice monthly)509 data points30 Sep 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3610 data points18 Sep 2019 to 20 Nov 2026